Literature DB >> 3728061

Duration of survival in senile dementia.

H F Diesfeldt, L R van Houte, R M Moerkens.   

Abstract

In this study 297 institutionalized patients with primary degenerative dementia were investigated. Age at onset of dementia was determined and individual longevity quotients (i.e. actual duration of survival divided by expected survival) were calculated. Expected survival was derived from the Dutch life tables for the general population. Age at onset of dementia was 75.6 +/- 7.8 years (mean +/- SD). Duration of dementia until death was 7.2 +/- 4.1 years. Dementia of early onset (before age 76) was associated with a significantly reduced life expectancy (LQ = 0.70 +/- 0.30), but this was not found for onset after age 75 (LQ = 0.91 +/- 0.58). Duration of symptoms at the time of admission into a nursing home was not associated with severity of behavioural and cognitive impairments as measured with behaviour rating scales. However, the severity of behavioural impairments predicted 1-year survival after admission, as could be shown by multivariate analysis which corrected for the effects of age and sex.

Entities:  

Mesh:

Year:  1986        PMID: 3728061     DOI: 10.1111/j.1600-0447.1986.tb02697.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  4 in total

Review 1.  Issues for clinical drug development in neurodegenerative diseases.

Authors:  Michel Dib
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Relation between cognitive impairment and early death in the elderly.

Authors:  J M Eagles; J A Beattie; D B Restall; F Rawlinson; S Hagen; G W Ashcroft
Journal:  BMJ       Date:  1990-01-27

3.  The US economic and social costs of Alzheimer's disease revisited.

Authors:  R L Ernst; J W Hay
Journal:  Am J Public Health       Date:  1994-08       Impact factor: 9.308

4.  Deaths attributable to Alzheimer's disease in the United States.

Authors:  D C Ewbank
Journal:  Am J Public Health       Date:  1999-01       Impact factor: 9.308

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.